Clinical Trials on Patients With Dyslipidemia

Total 13421 results

Amgen

Completed

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Dyslipidemia

United States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Czechia, Hungary, Taiwan, Colombia, Poland, Russian Federation, Switzerland, Korea, Republic of, Mexico, ... and more
Albireo

Completed

Study of A3309 in Patients With Dyslipidemia

Dyslipidemia

Sweden
Hospital Regional de Alta Especialidad de la Península...

Completed

Effect of Consumption of Chaya on Lipid Concentration and Antioxidant Status of Patients With Dyslipidemia

Dyslipidemias

Mexico
Arrowhead Pharmaceuticals

Active, not recruiting

Study of ARO-APOC3 in Adults With Dyslipidemia

Dyslipidemias

United States, Australia, Canada, Poland, Netherlands, New Zealand, Hungary
Zydus Therapeutics Inc.

Suspended

Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL

Dyslipidemias

United States
University of California, Davis
Unilever R&D

Completed

Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) Metabolism (HDL)

Dyslipidemia

United States
All India Institute of Medical Sciences, Bhubaneswar
Coconut Development Board, Government of India

Completed

Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia

Dyslipidemias

India
Organon and Co

Completed

Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)

Dyslipidemia
TC Erciyes University

Completed

The Effect Of Low-Fat And Low-Cholesterol Dietary Intervention On LDL Sub-Groups In Turkısh Dyslipidemic Patients

Dyslipidemias

Turkey
Yooyoung Pharmaceutical Co., Ltd.

Active, not recruiting

Phase 1 to Evaluate the Safety and Pharmacokinetic Characteristics of Fixed-dose Combination of YYC506

Dyslipidemias

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea

Dyslipidemias

Korea, Republic of
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels

Dyslipidemia

Turkey
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients. (DISSEMINATE)

Dyslipidemia

Malaysia
AstraZeneca
Parexel

Terminated

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD6615 in Healthy Subjects

Dyslipidemia

United States
Veloxis Pharmaceuticals

Completed

Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia

Dyslipidemia

United States
Canadian Collaborative Research Network
Valeant Canada Limited

Completed

Colesevelam, Lipids And Sugars, South Asian Canadian Trial (CLASS-ACT)

Dyslipidemia

Canada
Tufts University

Completed

Development of a Novel Method to Study in Vivo Fatty Acid Metabolism Using Stable Isotope Labeled Fatty Acids in Humans

Dyslipidemia

United States
Seoul National University Hospital

Unknown

Efficacy of Low-dose (10 mg) Rosuvastatin in Korean 4 Statin Benefit Groups Per 2013 ACC/AHA Guideline

Dyslipidemias
Chong Kun Dang Pharmaceutical

Completed

To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors

Dyslipidemias

Australia
Eli Lilly and Company

Completed

A Study of LY2484595 in Japanese Subjects

Dyslipidemias

Japan
Mansoura University

Unknown

Vitamin D Supplementation for Treatment of Dyslipidemia

Dyslipidemias

Egypt
Lesaffre International

Completed

Effect of Saccharomyces Cerevisiae in LDL Cholesterol (HONEY)

Dyslipidemias

France
The University of Hong Kong

Completed

The Effect of 3-Week Consumption of Soya Beverage Enriched With Plant Sterols on Serum LDL-C

Dyslipidemia

Hong Kong
Institute for Clinical Effectiveness and Health...

Completed

Statins at the Primary Care Level (EPRINA)

Dyslipidemia

Argentina
Chong Kun Dang Pharmaceutical

Completed

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects

Dyslipidemias

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1)

Dyslipidemia
Postgraduate Institute of Medical Education and...

Completed

Effect of Vitamin D Supplementation on Exercise Adaptations in Patients on Statin Therapy

Dyslipidemias

India
Azienda Ospedaliero-Universitaria di Parma
DOC generici srl

Completed

Efficacy and Tolerability of the Nutraceutical Formulation Coleosoma in Dyslipidemic Subjects (Coleosoma)

Dyslipidemias

Italy
Kuhnil Pharmaceutical Co., Ltd.

Completed

Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled (ROMANTIC)

Dyslipidemias
Xention Ltd

Completed

ADME Study in Healthy Male Subjects With TA-8995

Dyslipidemia

United Kingdom
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis (ENTHRALL)

Dyslipidemias

United States
The Hospital for Sick Children

Completed

Motivational Interviewing With Dyslipidemic Adolescents Together With a Parent Versus With Adolescents Alone: A Mixed Methods Clinical Trial

Dyslipidemias
University of Pennsylvania
Abbott

Completed

Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study (CENTAUR)

Dyslipidemia

United States
Merck Sharp & Dohme LLC

Completed

Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069)

Dyslipidemia
Merck Sharp & Dohme LLC

Completed

Fenofibrate Bioequivalence Study (0767-031)

Dyslipidemia
University of Palermo

Completed

Bergamot and Cardio-Metabolic Risk Factors

Dyslipidemia

Italy
Merck Sharp & Dohme LLC

Completed

A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093)

Dyslipidemia
Merck Sharp & Dohme LLC

Terminated

MK0354 Clinical Efficacy and Tolerability Study (0354-004)

Dyslipidemia
Merck Sharp & Dohme LLC

Terminated

Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)

Dyslipidemia
University of Alberta
AstraZeneca

Completed

A Community Based Approach to Dyslipidemia Management: Pharmacist Prescribing to Achieve Cholesterol Targets (RxACT)

Dyslipidemias

Canada
Merck Sharp & Dohme LLC

Completed

A Study of the Kinetics of a 13C-Cholesterol Infusate in Healthy Male Subjects (0000-108)(COMPLETED)

Dyslipidemia
Merck Sharp & Dohme LLC

Withdrawn

Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)

Dyslipidemia
Maastricht University Medical Center
DSM Nutritional Products, Inc.

Completed

Resveratrol and Serum Apo A-I

Dyslipidemia

Netherlands
AstraZeneca
Fundació Institut Català de Farmacologia

Withdrawn

Observational Study To Evaluate Statins Patterns Of Use In Spain

Dyslipidemia

Spain
Catabasis Pharmaceuticals

Completed

A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003

Dyslipidemia

United States
Akros Pharma Inc.

Completed

Safety Study of JTT-302 in Subjects With Low HDL-C Levels

Dyslipidemia

United States
UCSF Benioff Children's Hospital Oakland
Dairy Management Inc.

Completed

Effect of Saturated Fat on Large Low-density Lipoprotein (LDL) and High-density Lipoprotein (HDL)

Dyslipidemia

United States
Bristol-Myers Squibb

Completed

Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia

Dyslipidemia

United States, Canada
MaiHealth Inc

Unknown

Longitudinal Study of Multi-Analyte Profile for Dyslipidemia

Dyslipidemia

United States

3

Subscribe